Presented by Planned Parenthood {beacon} Healthcare Health Care PRESENTED BY The Big Story FDA panel gives nod to Moderna flu shot The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. The shot is...
FDA panel gives nod to Moderna flu shot
Political Leaning Analysis
Score: -0.02 •
Center / Neutral
Left
Center
Right
Story Timeline
Wed 23:00 - The Hill
FDA vaccine panel set to review Moderna mRNA flu shot
Thu 22:31 - The Hill
FDA panel recommends mRNA flu vaccine for older adults
Thu 23:37 - The Hill
FDA panel gives nod to Moderna flu shot